Monday, May 04, 2026 1:53:47 PM
I asked a bunch of LLM's if your message was actually truthful.
ChatGPT says: Most of it is inference dressed up as certainty. The core claim—“if it were revolutionary it would already be developed”—is not a reliable test of truth. Medical technologies often take decades, stall, restart, or fail to attract funding for reasons unrelated to efficacy. That timeline alone doesn’t prove anything.
Grok says: This is classic hindsight logic. Take a messy history, compress it into a neat story, and call it “reality.” The leap from “wasn’t picked up by big pharma” to “therefore it’s worthless” is just speculation, not evidence.
Claude says: The argument relies on assumptions about how innovation should progress. In practice, licensing decisions, funding constraints, and regulatory hurdles all influence development paths. These factors cannot be used on their own to determine the validity of a technology.
Copilot says: The message combines selected facts with broad conclusions. While some timeline elements may be accurate, the conclusions drawn from them—particularly about effectiveness or legitimacy—are not supported by evidence.
ChatGPT says: Most of it is inference dressed up as certainty. The core claim—“if it were revolutionary it would already be developed”—is not a reliable test of truth. Medical technologies often take decades, stall, restart, or fail to attract funding for reasons unrelated to efficacy. That timeline alone doesn’t prove anything.
Grok says: This is classic hindsight logic. Take a messy history, compress it into a neat story, and call it “reality.” The leap from “wasn’t picked up by big pharma” to “therefore it’s worthless” is just speculation, not evidence.
Claude says: The argument relies on assumptions about how innovation should progress. In practice, licensing decisions, funding constraints, and regulatory hurdles all influence development paths. These factors cannot be used on their own to determine the validity of a technology.
Copilot says: The message combines selected facts with broad conclusions. While some timeline elements may be accurate, the conclusions drawn from them—particularly about effectiveness or legitimacy—are not supported by evidence.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
